Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

6.47USD
22 Mar 2019
Change (% chg)

$-0.28 (-4.15%)
Prev Close
$6.75
Open
$6.67
Day's High
$6.82
Day's Low
$6.47
Volume
166,383
Avg. Vol
163,465
52-wk High
$7.84
52-wk Low
$5.01

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 4 0.05 0.10 0.03 --
Quarter Ending Jun-19 4 0.05 0.10 0.03 --
Year Ending Dec-19 4 0.16 0.30 0.12 2.27
Year Ending Dec-20 3 25.14 75.12 0.11 28.09
Earnings (per share)
Quarter Ending Mar-19 4 -0.16 -0.09 -0.18 --
Quarter Ending Jun-19 4 -0.18 -0.17 -0.20 --
Year Ending Dec-19 5 -0.73 -0.59 -0.87 -0.62
Year Ending Dec-20 4 -0.31 0.12 -0.57 -0.09
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.73 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta -- 1.08 0.87
Price to Sales (TTM) -- 49.53 8.39
Price to Book (MRQ) -- 10.19 5.27
Price to Tangible Book (MRQ) -- 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.73 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate -- 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) -- 3.50 2.98
LT Debt to Equity (MRQ) -- 19.47 11.35
Total Debt to Equity (MRQ) -- 32.15 16.02
Interest Coverage (TTM) -- -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.46 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.45 12.43
Operating Margin (TTM) -- -185.04 5.77
Operating Margin - 5 Yr. Avg. -- -126.93 8.02
Pre-Tax Margin (TTM) -- -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -- -132.72 8.31
Net Profit Margin (TTM) -- -182.45 1.53
Net Profit Margin - 5 Yr. Avg. -- -137.11 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.51 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,655,763 820,308,580
Net Income/Employee (TTM) -- 513,903 92,854,694
Receivable Turnover (TTM) -- 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) -- 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.37 10.60
Return on Assets - 5 Yr. Avg. -- 5.46 11.78
Return on Investment (TTM) -- 8.89 13.82
Return on Investment - 5 Yr. Avg. -- 6.77 15.32
Return on Equity (TTM) -- 10.02 15.24
Return on Equity - 5 Yr. Avg. -- 8.30 16.41

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.